Guardant Health, Inc. Financial Ratios — GH Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-36.22	-18.29	-9.76	-15.69	-18.13	-34.32	-28.23	-26.67	-23.79
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	12.38	36.56	52.33	67.01	67.73	67.11	65.23	59.74	60.79	64.46
EBITDA Margin (%)	-159.03	-143.26	-94.67	-33.1	-83.31	-104.04	-113.1	-92.53	-54.29	-40.48
Operating Margin (%)	-173.66	-153.71	-102.54	-38.42	-88.92	-110	-121.1	-100.14	-60.02	-44.53
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-182.71	-166.96	-92.92	-32.52	-85.76	-102.89	-145.36	-84.9	-58.87	-42.52
Profit Margin (%)	-182.74	-166.97	-93.85	-35.29	-88.51	-108.57	-145.61	-85.02	-59.05	-42.39
Net Income to Common Margin (%)	-182.74	-178.55	-93.85	-35.29	-88.51	-108.57	-145.61	-85.02	-59.05	-42.39
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	6.49	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	17	1	- -	40	854	1,374	1,369	1,354	1,336	1,710
ST Debt	- -	- -	- -	7	7	13	22	28	29	28
LT Debt	17	- -	- -	33	848	1,361	1,347	1,326	1,307	1,682
Total Debt/EBITDA	-0.42	-0.01	- -	-0.57	-3.58	-3.53	-2.69	-2.59	-3.33	-4.3
Net Debt/EBITDA	0.43	1.01	1.64	2.02	0.11	-1.65	-1.96	-0.01	-1.54	-2.83
Total Debt/EBIT	-0.39	-0.01	- -	-0.49	-3.35	-3.34	-2.52	-2.4	-3.01	-3.91
Net Debt/EBIT	0.39	0.94	1.51	1.74	0.1	-1.56	-1.83	-0.01	-1.39	-2.57
EBITDA to Interest Expense	-13.3	-26.43	-68.59	-60.08	-50.12	-150.85	-197.29	-202.42	-155.45	-102
EBITDA-CapEx/Interest Expense	-13.89	-29.75	-84.74	-78.11	-61.47	-179.96	-227.35	-210.37	-169.04	-114.4
EBIT to Interest Expense	-14.53	-28.35	-74.29	-69.75	-53.49	-159.49	-211.24	-219.06	-171.87	-112.2
Interest Expense	3	3	1	1	5	3	3	3	3	4
Common Equity/Total Assets	-92.33	-57.08	-47.8	-36.65	-26.7	-45.72	-103.26	-119.9	-173.55	-148.71
Long-Term Debt/Equity (%)	21.22	0.15	- -	3.92	62.55	210.99	2,238.96	835.51	- -	- -
Long-Term Debt/Capital (%)	18.91	0.15	- -	-12.65	277.99	371.92	-459.66	-168.23	-105.21	-131
Long-Term Debt/Total Assets (%)	14.51	0.13	- -	3.46	37.32	61.73	83.69	74.22	87.97	83.55
Total Debt/Equity (%)	21.38	0.21	0.02	4.76	63.03	212.98	2,275.31	853.12	-956.74	-1,722.08
Total Debt/Capital (%)	19.06	0.22	-0.04	-15.37	280.16	375.43	-467.13	-171.78	-107.56	-133.15
Total Debt/Total Assets (%)	14.62	0.19	0.02	4.2	37.61	62.31	85.05	75.78	89.93	84.93
Net Debt to Equity	-21.47	-23.42	-26.77	-16.89	-1.97	99.63	1,654.61	4.05	-441.83	-1,133.65
Net Debt/Capital (%)	-30.65	-31.07	37.04	35.27	5.05	-508.82	-229.03	-0.33	-34.9	-67.71
EBITDA	-40	-71	-86	-71	-239	-389	-508	-522	-401	-398
EBITDA-CapEx	-42	-80	-106	-92	-293	-464	-586	-542	-436	-446
Operating Income (Loss)	-44	-77	-93	-82	-255	-411	-544	-565	-444	-437

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	6.67	11.28	8.92	7.19	26.87	4.79	5.23	5.68	3.72	3.97
Current Ratio	7.22	12.38	9.99	8.21	28.27	5.72	6.17	6.54	4.68	4.84
Quick Ratio	6.92	11.93	9.68	7.85	27.66	5.29	5.74	6.11	4.21	4.42
CFO/Avg Current Liab	- -	-4.26	-2.17	-0.79	-1.49	-1.6	-1.6	-1.63	-1.11	-0.7
Common Equity/Total Assets	-92.33	-57.08	-47.8	-36.65	-26.7	-45.72	-103.26	-119.9	-173.55	-148.71
Long-Term Debt/Equity (%)	21.22	0.15	- -	3.92	62.55	210.99	2,238.96	835.51	- -	- -
Long-Term Debt/Capital (%)	18.91	0.15	- -	-12.65	277.99	371.92	-459.66	-168.23	-105.21	-131
Long-Term Debt/Total Assets (%)	14.51	0.13	- -	3.46	37.32	61.73	83.69	74.22	87.97	83.55
Total Debt/Equity (%)	21.38	0.21	0.02	4.76	63.03	212.98	2,275.31	853.12	-956.74	-1,722.08
Total Debt/Capital (%)	19.06	0.22	-0.04	-15.37	280.16	375.43	-467.13	-171.78	-107.56	-133.15
Total Debt/Total Assets (%)	14.62	0.19	0.02	4.2	37.61	62.31	85.05	75.78	89.93	84.93
CFO/Total Liabilities	-99.57	-210.4	-115.59	-41.15	-11.34	-13.4	-19.97	-19.96	-14.76	-8.74
CFO/CapEx	-20.79	-8.04	-3.57	-2.21	-1.92	-2.79	-4	-15.86	-6.84	-3.82
Altman's Z-Score	-1.4	-0.63	10.8	37.17	8.58	3.31	-0.48	-0.53	-0.88	1.93

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	6.12	3.74	5.12	5.66	4.95	4.61	6.23	7.75	8.2
Days Sales Outstanding	- -	59.62	97.61	71.23	64.47	73.73	79.13	58.62	47.1	44.51
Inventory Turnover	- -	6.29	5.26	5.82	4.88	4.6	3.8	4	4.36	4.45
Days Inventory Outstanding	- -	58.04	69.36	62.75	74.74	79.27	96.05	91.27	83.78	82.08
Accounts Payable Turnover	- -	8.86	5.76	5.72	8.5	5.71	3.3	3.94	6.62	7.82
Accounts Payable Turnover Days	- -	41.19	63.35	63.81	42.92	63.95	110.61	92.75	55.12	46.65
Cash Conversion Cycle	- -	76.48	103.63	70.18	96.28	89.05	64.56	57.13	75.75	79.94
Inventory to Cash Days	- -	1.57	28.24	8.48	-10.27	-5.55	-16.92	-32.65	-36.67	-37.57
Inventories	3	7	9	15	23	31	52	62	71	86
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	3	7	9	15	23	31	52	62	71	86

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	1,143	7,079	12,566	10,133	2,779	3,029	3,750	12,806
- Cash & Cash Equivalents	34	72	141	143	833	492	142	1,134	526	378
+ Preferred Equity and Hybrid Capital	180	500	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	42	50	57	- -	- -	- -	- -	- -
+ Total Debt	17	1	- -	40	854	1,374	1,369	1,354	1,336	1,710
Enterprise Value	102	279	766	6,646	11,683	10,574	3,137	3,214	4,246	13,314
Total Capital	89	305	-239	-263	305	366	-293	-788	-1,242	-1,284
Total Debt/Capital (%)	19.06	0.22	-0.04	-15.37	280.16	375.43	-467.13	-171.78	-107.56	-133.15
Total Debt / EV	0.17	- -	- -	0.01	0.07	0.13	0.44	0.42	0.31	0.13
EV/Sales	4.03	5.6	8.45	31	40.75	28.3	6.98	5.7	5.75	13.56
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	1,143	7,079	12,566	10,133	2,779	3,029	3,750	12,806
Diluted Enterprise Value	163	428	1,044	7,026	12,645	11,015	4,007	3,250	4,560	14,138
EV per Share	1.44	3.95	25.19	73.36	119.82	104.37	30.7	28.7	34.59	106.2
TTM Sales	25	50	91	214	287	374	450	564	739	982
TTM EBITDA	-40	-71	-86	-71	-239	-389	-508	-522	-401	-398
TTM Operating Income	-44	-77	-93	-82	-255	-411	-544	-565	-444	-437
TTM Cash Flow to Firm	-34	-70	-71	-46	-99	-206	-307	-322	-237	-181
TTM Free Cash Flow to Firm	-32	-61	-51	-25	-45	-131	-229	-302	-202	-133

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-21.99	-273.87	-251.99	-75.63	-11.98	-9.95	-18.31	-93.85
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	102	279	766	6,646	11,683	10,574	3,137	3,214	4,246	13,314
Low Price	- -	- -	27.04	33.7	55.9	85.41	24.63	20.67	15.81	30.97
EV/Sales	4.03	5.6	8.45	31	40.75	28.3	6.98	5.7	5.75	13.56
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-13.17	-87.65	-35.01	-31.63	-8.39	-6.93	-7.13	-17.55
Price/Earnings High	- -	- -	-17.71	-134.38	-53.27	-45.22	-16.05	-9.59	-10.84	-33.86
Price/Earnings Low	- -	- -	-9.66	-40.36	-21.48	-21.33	-3.84	-4.83	-4.45	-9.33
Price/Book Value	- -	- -	-4.07	-20.07	-20.72	-10.05	-1.67	-1.41	-1.45	-4.28
Price/Book Value Average	- -	- -	-3.99	-18.79	-14.65	-12.73	-3.3	-1.55	-1.21	-2.44
Price/Book Value High	- -	- -	-5.36	-28.82	-22.29	-18.2	-6.32	-2.15	-1.83	-4.71
Price/Book Value Low	- -	- -	-2.93	-8.65	-8.99	-8.59	-1.51	-1.08	-0.75	-1.3
Price/Tangible Book Value	- -	- -	2.21	8.54	9.4	16.15	61.54	20.69	-25.05	-63.24
Price/Tangible Book Value Average	- -	- -	2.17	8	6.65	20.45	121.53	22.7	-20.79	-36.07
Price/Tangible Book Value High	- -	- -	2.91	12.26	10.12	29.23	232.69	31.41	-31.59	-69.61
Price/Tangible Book Value Low	- -	- -	1.59	3.68	4.08	13.79	55.72	15.81	-12.96	-19.18
Price/Sales	- -	- -	12.61	33.02	43.83	27.12	6.18	5.37	5.07	13.04
Price/Sales Average	- -	- -	12.36	30.93	30.98	34.34	12.21	5.89	4.21	7.44
Price/Sales High	- -	- -	16.62	47.42	47.15	49.1	23.38	8.15	6.4	14.35
Price/Sales Low	- -	- -	9.07	14.24	19.01	23.16	5.6	4.1	2.63	3.95
Price/Cash Flow	- -	- -	-15.83	-150.19	-120.91	-48.48	-8.98	-9.32	-15.63	-69.31
Price/Cash Flow Average	- -	- -	-15.52	-140.68	-85.48	-61.39	-17.74	-10.23	-12.97	-39.53
Price/Cash Flow High	- -	- -	-20.87	-215.69	-130.08	-87.77	-33.96	-14.15	-19.72	-76.29
Price/Cash Flow Low	- -	- -	-11.39	-64.77	-52.45	-41.4	-8.13	-7.12	-8.09	-21.02
Price/Free Cash Flow Average	- -	- -	-21.55	-256.52	-178.15	-95.77	-23.66	-10.92	-15.2	-53.53
Price/Free Cash Flow High	- -	- -	-28.98	-393.3	-271.09	-136.92	-45.3	-15.1	-23.1	-103.3
Price/Free Cash Flow Low	- -	- -	-15.82	-118.11	-109.3	-64.59	-10.85	-7.6	-9.48	-28.46
EV/Sales Average	6.47	8.59	11.27	30.68	31.26	36.7	14.94	6.28	5.31	8.79
EV/Sales High	6.47	8.59	15.53	47.17	47.42	51.46	26.11	8.54	7.5	15.71
EV/Sales Low	6.47	8.59	7.98	13.99	19.28	25.52	8.33	4.5	3.72	5.31
EV/EBITDA Average	-4.07	-6	-11.9	-92.69	-37.52	-35.28	-13.21	-6.79	-9.78	-21.73
EV/EBITDA High	-4.07	-6	-16.41	-142.52	-56.92	-49.46	-23.08	-9.23	-13.81	-38.81
EV/EBITDA Low	-4.07	-6	-8.43	-42.28	-23.15	-24.53	-7.36	-4.86	-6.86	-13.12
EV/EBIT Average	-3.73	-5.59	-10.99	-79.85	-35.16	-33.37	-12.34	-6.28	-8.84	-19.75
EV/EBIT High	-3.73	-5.59	-15.15	-122.78	-53.33	-46.78	-21.56	-8.53	-12.49	-35.28
EV/EBIT Low	-3.73	-5.59	-7.78	-36.42	-21.69	-23.2	-6.88	-4.49	-6.2	-11.93
Last Price	- -	- -	37.59	78.14	128.88	100.02	27.2	27.05	30.55	102.14
High Price	- -	- -	49.55	112.22	138.65	181.07	102.85	41.06	38.53	112.43
Enterprise Value Average	163	428	1,021	6,577	8,963	13,713	6,717	3,544	3,922	8,636
Enterprise Value High	163	428	1,408	10,113	13,598	19,226	11,737	4,818	5,540	15,428
Enterprise Value Low	163	428	723	3,000	5,529	9,535	3,744	2,535	2,751	5,215

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	84	84	86	94	100	102	103	122	124	131
Diluted Weighted Avg Shares	71	71	30	91	98	101	102	112	123	125
Basic Weighted Avg Shares	71	71	30	91	98	101	102	112	123	125
Revenue per Share	0.36	0.7	2.98	2.37	2.94	3.69	4.4	5.04	6.02	7.83
EBITDA per Share	-0.57	-1.01	-2.82	-0.78	-2.45	-3.84	-4.98	-4.66	-3.27	-3.17
Operating Income per Share	-0.62	-1.08	-3.06	-0.91	-2.61	-4.06	-5.33	-5.04	-3.61	-3.49
Basic EPS, GAAP	-0.65	-1.26	-2.8	-0.84	-2.6	-4	-6.41	-4.28	-3.56	-3.32
Basic EPS from Cont Ops	-0.65	-1.18	-2.77	-0.75	-2.53	-3.8	-6.41	-4.28	-3.56	-3.32
Diluted EPS, GAAP	-0.65	-1.26	-2.8	-0.84	-2.6	-4	-6.41	-4.28	-3.56	-3.32
Diluted EPS from Cont Ops	-0.65	-1.18	-2.77	-0.75	-2.53	-3.8	-6.41	-4.28	-3.56	-3.32
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.52	-1.02	-2.37	-0.52	-1.07	-2.06	-3.03	-2.9	-1.95	-1.47
Free Cash Flow per Basic Share	-0.54	-1.15	-3.04	-0.76	-1.62	-2.8	-3.79	-3.08	-2.24	-1.86
Cash & Equivalents per Share	1.35	3.13	13.78	5.77	18.41	9.21	9.9	10.44	6.84	9.58
Book Value per Share	-1.52	-2.77	-9.24	-3.89	-6.22	-9.95	-16.27	-19.13	-21	-23.88
Tangible Book Value per Share	-1.42	-2.83	17.01	9.15	13.7	6.19	0.44	1.31	-1.22	-1.62

Guardant Health, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)